Simple treatment tweak drastically reduces blood loss from severe cuts

Researchers at McGill University have developed a simple modification to red blood cells that drastically reduces blood loss from severe wounds. In experiments on rats with serious liver injuries, the treated blood formed clots within five seconds, compared to over four minutes in untreated animals, resulting in minimal blood loss. The modified clots also persisted for one to two months, potentially allowing more time for wound healing. This breakthrough could significantly improve outcomes in both planned surgeries and emergency bleeding situations. The technique involves chemically altering red blood cells to strengthen their natural role in clot formation. Normally fragile, red blood cells combine with platelets to create a sticky mesh that plugs wounds, but the new method uses chemical "handles" to link cells together more robustly. After modification, the cells are reintroduced into plasma and injected into wounds, rapidly triggering clotting. The treated rats lost only 24 milligrams of blood on average, compared to nearly 2000 milligrams in controls, and showed no adverse effects during the extended clot lifespan. This approach addresses a critical global health issue, as uncontrolled bleeding causes around two million deaths annually. Current treatments like transfusions and bandages can be costly, slow to administer, or cause immune reactions. The ability to prepare modified blood from a patient’s own sample within 30 minutes could streamline surgical care, while pre-prepared blood-bank products might be used in emergencies. However, experts note challenges remain, including the shorter shelf life of cellular materials compared to synthetic alternatives. The research team has filed a patent and envisions future clinical applications that harness this cell-based biomaterial technology to improve surgical and regenerative medicine. If successfully translated to humans, the method could revolutionize bleeding control and wound healing, reducing mortality and complications associated with severe blood loss.